Tryton Medical, Inc. was founded in 2003 by Aaron V. Kaplan, M.D. and Spray Venture Partners with a single mission: to become the leading developer of novel stent systems for the treatment of bifurcation lesions.Tryton's innovative solution to the persistent problem presented by bifurcation lesions is the Tryton Side Branch Stent System™, which offers a dedicated strategy for bifurcation stenting. This unique system has demonstrated excellent initial clinical results and is available in Europe.